Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edivoxetine in Major Depressive Disorder
NCT00420004Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of edivoxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Dec 2006; status: completed.
02
Drugs
edivoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00420004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420004.